Logo

American Heart Association

  18
  0


Final ID: MP2184

Performance of the PREVENT ASCVD Risk Calculator Across Asian American, Native Hawaiian, and other Pacific Islander Individuals: The PANACHE Study

Abstract Body (Do not enter title and authors here): Introduction: Accurately predicting 10-year ASCVD risk is key to guide primary prevention, yet little is known about how the AHA PREVENT ASCVD equation performs in disaggregated Asian American, Native Hawaiian, and Pacific Islander (AANHPI) adults.

Hypothesis: We hypothesized the performance of the PREVENT ASCVD equations varies across contemporary AANHPI groups.

Goal: To evaluate discrimination and calibration of the PREVENT ASCVD equations in 8 major AANHPI groups (Chinese, Filipino, Native Hawaiian/other Pacific Islander [NH/PI], Japanese, Korean, South Asian, Vietnamese, other Southeast Asian) and Non-Hispanic Whites (NHW).

Methods: We identified all members aged 30-79 years of Kaiser Permanente (KP) Northern California and KP Hawaii integrated healthcare delivery systems from 2012-2022 who had no prior CVD and had complete data to estimate the PREVENT ASCVD risk using the base and full models. Incident ASCVD events (non-fatal and fatal MI and stroke) were identified through December 2023 using validated ICD-9/10 diagnosis codes in EHR and vital status data, and observed risk calculated using a cause-specific risk model that accounted for competing risk of non-ASCVD death. We examined model discrimination (C-index) and calibration (calibration plot and slope) by individual AANHPI group.

Results: We identified 1,219,255 eligible adults, with mean (SD) age ranging from 44.4 (13.2) years in South Asian to 61.0 (15.4) years in Japanese; 54.6% were women and there were higher proportions of women in Japanese, Korean, and NHW groups. Discrimination of the PREVENT base and full models was good overall and consistent across AANHPI individuals, with C statistics ranging from 0.77 (Japanese, Korean) to 0.82 (Chinese, South Asian) (Figure 1-3). However, calibration for the PREVENT base equation varied across AANHPI individuals, with underestimation of actual 10-year ASCVD risk in NH/PI, South Asian and other Southeast Asian adults, and overestimation in Chinese, Japanese, Korean and Vietnamese adults. The PREVENT full equation lowered predicted ASCVD risk in all groups (Figure).

Conclusions: In a large, contemporary, primary prevention population of AANHPI and NHW adults in California and Hawaii, the PREVENT ASCVD equations had good discrimination but variable calibration across 8 major AANHPI individual groups. Given primary prevention decisions rely on predicted absolute risks, our findings support further optimizing ASCVD risk equations in targeted AANHPI groups.
  • Go, Alan  ( KAISER PERMANENTE NORTHERN CAL , Pleasanton , California , United States )
  • Parikh, Rishi  ( KAISER PERMANENTE NORTHERN CAL , Pleasanton , California , United States )
  • Ambrosy, Andrew  ( KAISER PERMANENTE NORTHERN CAL , Pleasanton , California , United States )
  • Tan, Thida  ( KAISER PERMANENTE NORTHERN CAL , Pleasanton , California , United States )
  • Alexeeff, Stacey  ( KAISER PERMANENTE NORTHERN CAL , Pleasanton , California , United States )
  • Howick, Connor  ( Kaiser Permanente Hawaii , Honolulu , Hawaii , United States )
  • Lo, Joan  ( KAISER PERMANENTE NORTHERN CAL , Pleasanton , California , United States )
  • Daida, Yihe  ( Kaiser Permanente Hawaii , Honolulu , Hawaii , United States )
  • Author Disclosures:
    Alan Go: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers-Squibb:Active (exists now) ; Research Funding (PI or named investigator):Edwards Life Sciences:Active (exists now) ; Research Funding (PI or named investigator):Novartis:Past (completed) | Rishi Parikh: DO NOT have relevant financial relationships | Andrew Ambrosy: DO have relevant financial relationships ; Consultant:Bayer:Expected (by end of conference) ; Consultant:BMS:Expected (by end of conference) ; Consultant:Novo Nordisk:Past (completed) ; Consultant:Merck:Past (completed) ; Researcher:BI:Active (exists now) ; Researcher:Abiomed:Active (exists now) ; Researcher:Bayer:Active (exists now) | Thida Tan: DO NOT have relevant financial relationships | Stacey Alexeeff: No Answer | Connor Howick: DO NOT have relevant financial relationships | Joan Lo: DO NOT have relevant financial relationships | Yihe Daida: DO have relevant financial relationships ; Research Funding (PI or named investigator):Sanofi:Past (completed) ; Research Funding (PI or named investigator):Vir Biotechnology:Past (completed) ; Research Funding (PI or named investigator):Gilead:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Aging, Biological Age & Cardiovascular Risk

Monday, 11/10/2025 , 10:45AM - 11:45AM

Moderated Digital Poster Session

More abstracts on this topic:
Applying a comprehensive cardiometabolic risk prediction model to real-world primary care patient data

Howell Carrie, Tanaka Shiori, Burkholder Greer, Mehta Tapan, Herald Larry, Garvey William, Cherrington Andrea

A novel reproducible low-cost model of acute myocardial infarction in swine

Li Yichen, Zheng Zilong, Tang Weijie, Chen Wangping, Yang Jinfu, Fan Chengming

More abstracts from these authors:
Incidence of Diagnosed Atrial Fibrillation in Community-Based Asian American, Native Hawaiian and other Pacific Islander Subpopulations: Findings from the PANACHE Study

Go Alan, Ambrosy Andrew, Parikh Rishi, Tan Thida, Howick Connor, Alexeeff Stacey, Lo Joan, Daida Yihe

BMI Thresholds and Incident ASCVD in Disaggregated Asian American, Native Hawaiian and other Pacific Islander Men and Women: The PANACHE Study

Go Alan, Parikh Rishi, Tan Thida, Ambrosy Andrew, Alexeeff Stacey, Howick Connor, Daida Yihe, Lo Joan

You have to be authorized to contact abstract author. Please, Login
Not Available